Antibody cocktail effective against emerging Covid-19 Omicron variants
Drug Discovery World
JANUARY 16, 2024
Biotech company ExeVir Bio has revealed new data demonstrating that its antibodies are effective in neutralising currently circulating Covid-19 Omicron variants. The company says that all authorised SARS-CoV-2 therapeutic antibodies that have been used in the clinic show severe to complete loss of virus neutralisation potency against the currently circulating variants.
Let's personalize your content